Latest filing published 15 Dec 2010 for ReShape Lifesciences Inc..
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
This profile gathers the share dealings of Nicholas Teti across 3 companies, led by Fibrocell Science, Inc., Inamed Corp and ReShape Lifesciences Inc. Between 17 March 2006 and 14 December 2010, the trades on record add up to 11 filings.
On the market, this insider has only ever bought: 8 purchases, €100k in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
Half of the purchases are above €7,861 and half below.
On 15 December 2010 came the latest disclosure, a transaction in ReShape Lifesciences Inc. The clock since the last published purchase (17 September 2007) now reads 6,977 days. Typically, a trade is published a median of 4 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 of 11 declarations